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Abstract
Background: Protein and mRNA levels for several selenoproteins, such as glutathione peroxidase-1 (Gpx1), are
down-regulated dramatically by selenium (Se) deficiency. These levels in rats increase sigmoidally with increasing
dietary Se and reach defined plateaus at the Se requirement, making them sensitive biomarkers for Se deficiency.
These levels, however, do not further increase with super-nutritional or toxic Se status, making them ineffective for
detection of high Se status. Biomarkers for high Se status are needed as super-nutritional Se intakes are associated
with beneficial as well as adverse health outcomes. To characterize Se regulation of the transcriptome, we
conducted 3 microarray experiments in weanling mice and rats fed Se-deficient diets supplemented with up to
5 μg Se/g diet.
Results: There was no effect of Se status on growth of mice fed 0 to 0.2 μg Se/g diet or rats fed 0 to 2 μg Se/g
diet, but rats fed 5 μg Se/g diet showed a 23% decrease in growth and elevated plasma alanine aminotransferase
activity, indicating Se toxicity. Rats fed 5 μg Se/g diet had significantly altered expression of 1193 liver transcripts,
whereas mice or rats fed ≤ 2 μg Se/g diet had < 10 transcripts significantly altered relative to Se-adequate animals
within an experiment. Functional analysis of genes altered by Se toxicity showed enrichment in cell movement/
morphogenesis, extracellular matrix, and development/angiogenesis processes. Genes up-regulated by Se
deficiency were targets of the stress response transcription factor, Nrf2. Multiple regression analysis of transcripts
significantly altered by 2 μg Se/g and Se-deficient diets identified an 11-transcript biomarker panel that accounted
for 99% of the variation in liver Se concentration over the full range from 0 to 5 μg Se/g diet.
Conclusion: This study shows that Se toxicity (5 μg Se/g diet) in rats vastly alters the liver transcriptome whereas
Se-deficiency or high but non-toxic Se intake elicits relatively few changes. This is the first evidence that a vastly
expanded number of transcriptional changes itself can be a biomarker of Se toxicity, and that identified transcripts
can be used to develop molecular biomarker panels that accurately predict super-nutritional and toxic Se status.
Background
The selenoenzyme glutathione peroxidase-1 (Gpx1) is
highly regulated by dietary Se, decreasing in Se deficiency
to < 1% of Se adequate levels in Se-deficient liver [1].
This sensitive regulation has made Gpx1 activity a useful
biomarker for determining the dietary requirement for
Se, which in rodents is 0.1 μg Se/g diet (1X requirement)
when based on this marker [2]. In addition to Gpx1 activ-
ity, Gpx1 mRNA is also dramatically down-regulated in
Se deficiency [3], and Gpx1 mRNA can also be used to
determine Se requirements [4-7]. Recently, our study on
Se-regulation of the full selenoproteome in rats showed
that several additional selenoprotein mRNAs are highly
regulated by Se status and can also be used as biomarkers
of Se deficiency [8]. The resulting Se requirements based
on selenoprotein mRNAs (0.03 to 0.07 μg Se/g diet) are
slightly lower than requirements based on selenoenzyme
activity (0.06 to 0.13 μg Se/g diet), but importantly, none
of these mRNAs are further increased in rats fed super-
nutritional levels of dietary Se up to 8-times the require-
ment. These studies demonstrated that selenoprotein
mRNAs are useful molecular biomarkers for Se defi-
ciency, but are not effective in assessing high Se status.
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sue Se concentration and changes in fingernail morphol-
ogy, are lacking in specificity and sensitivity [9].
Molecular biomarkers are potentially better predictors
of physiological effects associated with high Se intakes
[10], but so far studies on the transcriptional effects of
super-nutritional Se have not identified well-regulated
molecular biomarkers of high Se status. In rodents sev-
eral microarray studies have found 14 to 242 genes
altered by a Se intake of 1.0 μg Se/g as compared to Se-
deficient diets, but the only consistently regulated genes
in these studies were the selenoproteins [11-13], sug-
gesting that the Se-specific effects detected were primar-
ily caused by Se deficiency and not high Se. Studies on
the transcriptional effects of Se in various cancer cell
lines and cancerous tissue have also produced variable
results, with little similarity between studies [14-18].
The lack of genes consistently regulated by high Se in
these microarray studies suggests that the genes so far
identified may not be useful as Se-specific molecular
biomarkers.
The current recommended dietary allowance (RDA) for
adult humans is 55 μg/day (1X requirement), and the tol-
erable upper intake level (UL) for Se in humans has been
set at 400 μg/day, which is about 8-times the requirement
[9]. High Se intake has long been associated with preven-
tion of cancer [19], but clinical trials of Se supplementa-
tion for cancer prevention in humans have produced
inconsistent results. The Nutritional Prevention of
Cancer Trial (NPCT) found that supplementation with
200 μg/day of high Se yeast (4X requirement) signifi-
cantly decreased risk for prostate, lung, and colorectal
cancer in patients with previous skin cancers, although
no effect on recurrence of skin cancer was observed [20].
More recently, the Selenium and Vitamin E Cancer Pre-
vention Trial (SELECT), which enrolled >35,000 men,
found no effect of Se supplementation on prostate or any
other cancer [21]. Follow-up studies on the NPCT sub-
jects, however, found that Se supplementation increased
the risk of squamous cell carcinoma [22], total cancer
incidence [23], and diabetes [24] in subjects with higher
initial plasma Se levels. Furthermore, a significant nega-
tive relationship between plasma Se level and diabetes
risk was observed in National health and nutrition exami-
nation survey (NHANES) 2003-2004 subjects [25], and
SELECT found a trend for increased type II diabetes risk
in the Se supplemented group [21]. These reports of
advantages and adverse effects associated with super-
nutritional Se highlight the need to better understand the
transcriptional effects of high Se intakes.
To characterize Se regulation of the transcriptome,
we conducted 3 microarray studies in rodents fed diets
supplemented with graded levels of Se from Se-deficient
to 5 μg Se/g diet, or 50-times the requirement.
Our objectives were to determine the transcriptional
response to Se deficiency, super-nutritional, and toxic Se
intakes in our well-characterized rodent model to identify
candidates for genes regulated by high Se status, to pro-
vide insight into the molecular mechanisms underlying
how animals homeostatically adapt to high Se status, and
to determine whether identified Se-regulated genes could
be used as molecular biomarkers of high Se status.
Results
Animal Growth
In all experiments, initial body weights of treatment
groups were not significantly different. In the mouse
study and in rat study 1 there were no significant differ-
ences in growth due to dietary Se level [8,26], consistent
with previous studies [4,5]. In rat study 2, however, rats
fed 5 μg Se/g diet had significantly lower body weight as
compared to all other diet groups (P < 0.05) starting at
day 10 and continuing for the remainder of the study
(Figure 1). In rat study 2, the initial body weight averaged
53 g, and the final average weight of rats fed 5 μgS e / g
diet was 193 ± 8 g vs. an average of 251 ± 5 g (P <
0.0006) for all other diet groups.
Se Status of Animals using Conventional Biomarkers
Se concentration in liver, Gpx1 activity in liver and red
blood cells (RBCs), and Gpx3 activity in plasma were
measured for each study to determine the Se status of
the animals. The regulation of selenoenzyme activities in
the mouse study and rat study 1 are described in detail
in previous reports using these animals [8,26]. Briefly, Se
concentration and Gpx1 activity in mouse liver and
Gpx1 activity in RBC dropped in Se deficiency to 4, 3.5,
and 37%, respectively, of Se-adequate (0.2 μgS e / g )
Figure 1 Effect of dietary Se on rat body weight. Male weanling
rats were supplemented with 0 to 5 μg Se/g diet for 28 d and
weighed bi-weekly. Values are means ± SEM, n = 4/diet. At each
timepoint, values marked with an asterisk are significantly different
from all other weights (P < 0.05).
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mice dropped to 13% of Se-adequate levels. Liver Se and
Gpx activities in mice fed the Se-marginal diet (0.05 μg
Se/g diet) were intermediate between Se-deficient and
Se-adequate mice. In rat study 1, liver and RBC Gpx1
activities in Se deficiency were 2 and 24%, respectively,
of Se-adequate levels (0.24 μg Se/g), and increased
to plateau levels by 0.09 and 0.08 μg Se/g diet, respec-
tively. In Se-deficient rats, plasma Gpx3 activity was 2%
of adequate levels and reached the plateau by 0.06 μg
Se/g diet.
Liver Se concentration in Se-deficient rats in both rat
study 1 and 2 decreased to 3% of Se-adequate levels
(0.24 μg Se/g) (not shown and Figure 2A), similar to the
mouse study. In rat study 1, liver Se increased to a pla-
teau at 0.08 μg Se/g diet, remained at this level until
0.24 μg Se/g diet, and then increased gradually to 180%
of Se adequate levels in rats fed 0.8 μgS e / gd i e t[ 8 ] .I n
rat study 2, liver Se followed exactly the same pattern as
in rat study 1 (Figure 2A) and then increased to 338%
and 439% of Se-adequate levels in rats fed 2 and 5 μg
Se/g, respectively.
In rat study 2, liver Gpx1 activity in Se-deficient rats
dropped to 2% of Se-adequate (0.24 μgS e / g )l e v e l s
(Figure 2B) and liver Gpx1 activities were clearly on the
plateau in rats fed >0.08 μg Se/g diet. A decrease in
liver Gpx1 activity to 77% of Se-adequate levels was
observed in rats fed 5 μg Se/g diet, similar to previous
results [1]. This decrease may be attributed to an overall
lowering of enzyme activity due to liver damage (see
below). Liver Gpx4 activity in Se-deficient rats only
decreased to 30% of Se-adequate levels and reached pla-
teau levels by 0.08 μg Se/g diet (Figure 2C), as reported
previously [5]. While RBC Gpx1 activity in Se-deficient
rats from study 2 decreased to 26% of Se-adequate
levels, RBC Gpx1 activity continued to increase with
increasing levels of Se supplementation (Figure 2D)
unlike the other tissues examined. This is consistent
with previous reports [1,4,5], and is likely attributed to
the long half life of RBCs and the relatively rapid devel-
opment of the young rapidly growing rats, as RBC Gpx1
activity reaches a defined plateau in older rats [7,27].
Plasma Gpx3 activity in Se-deficient rats in rat study
2 was 3.5% of adequate, with a clear plateau above
0.08 μg Se/g diet (Figure 2C), similar to rat study 1.
ALT and AST Activity Analyses
The reduced growth in rats fed 5 μgS e / gd i e tw a st h e
first indication in this study of an adverse effect of this
level of dietary Se. Alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) activities in plasma
were measured as markers of liver damage as these had
previously been shown to increase at high Se intakes
[28]. ALT activity was significantly increased in 5 μg Se/g
diet rats as compared to all other diet groups, and was
approximately twice that of Se-adequate (0.24 μgS e / g )
rats (Figure 3). AST activity also showed a significant
near 2-fold increase in 5 μgS e / gr a t sa sc o m p a r e d
to Se-adequate rats (Figure 3), but in contrast to ALT,
AST activity was significantly higher in the 2 μgS e / g
Figure 2 Effect of Se status on liver Se and Gpx activities in rats.
Liver Se (A), Liver Gpx1 (B), Gpx4 (C), and RBC Gpx1 and plasma Gpx3
(D) activities in male weanling rats fed diets supplemented with 0 to
5 μg Se/g diet for 28 d. Values are means ± SEM, n = 4/diet. The level
of significance by ANOVA is indicated in each panel; values with a
common letter are not significantly different (P ≥ 0.05).
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resulting in a U-shaped curve. Increased AST activity in
Se-deficient plasma has been observed in other studies in
our lab (unpublished results).
Dietary Se regulation of the transcriptome
To determine the effect of Se status on general transcrip-
tion, whole genome microarrays (Mouse Genome 430 2.0
and Rat Genome 230 2.0 arrays, Affymetrix, Santa Clara,
CA) were used to compare gene expression in the liver
or kidney of rodents fed Se-deficient and high Se diets vs.
Se-adequate diets. To obtain a global picture of the effect
of dietary Se on transcription, robust multichip averaging
(RMA) expression for each Se treatment group (average
values, n = 3/group) was plotted against expression from
the Se-adequate group (0.2 μg Se/g, mouse study; 0.24 μg
Se/g, rat studies). In the mouse study, this analysis
showed a relatively tight clustering of expression along
the 1:1 line for both 0 and 0.05 μg Se/g (data not shown).
Similarly, analysis of 0.08 and 0.8 μg Se/g datasets
from rat study 1 (Figure 4B, C) and of 0 and 2 μgS e / g
datasets from rat study 2 showed tight 1:1 expres-
sion (Figure 4A, D). In contrast, there was an obvious
expanded scattering of expression outside the 2-fold
change lines in the 5 vs. 0.24 μg Se/g diet analysis (Figure
4E), clearly showing the unique transcriptional effects eli-
cited by toxic Se intake. The tightness of expression in
the 0.8 vs. 0.24 μg Se and 2 vs. 0.24 μgS ea n a l y s e sa r e
particular striking, given that these levels are 8 and
20 times the Se requirement in the rat [2,4].
Transcriptional regulation by Se deficiency
Se-deficient treatment groups were included in these
microarray studies in order to assess Se status across
the full range from Se-deficient to toxic Se status, to
further characterize the effect of Se deficiency on the
transcriptome, and to be able to distinguish the effects
of Se deficiency from Se excess. Our previous studies
[8,26] showed that expression of a subset of the 24
rodent selenoproteins is down-regulated by Se defi-
ciency. For these studies the full complement of non-
selenoprotein genes was evaluated for regulation by Se
status. In the mouse study, Se deficiency significantly
up-regulated 3 genes in liver (Cbr3, Abcc4, and Hspb1),
with 4 additional genes nearly significant (P < 0.2) as
compared to Se-adequate (0.2 μg Se/g) mice (Table 1).
No genes were significantly up-regulated in Se-deficient
kidney as compared to Se-adequate kidney (Table 1).
Similarly, in rat study 2 there were only 2 genes signifi-
cantly up-regulated (Gsta5 and LOC286989) in Se-defi-
cient vs. Se-adequate (0.24 μg Se/g) rats (Table 1).
A few genes or gene families are up-regulated in all 3
Se-deficient datasets, although these did not reach sig-
nificance in every treatment. NAD(P)H dehydrogenase,
quinone 1 (Nqo1), and members of the ATP-binding
cassette subfamily C and glutathione transferase-alpha
family were consistently up-regulated by Se deficiency.
Se deficiency significantly down-regulated 5 genes in
mouse liver, 3 genes in mouse kidney, and 4 genes in
rat liver; these were all selenoproteins previously
reported to be highly regulated by Se [8,26] (Table 2),
and there were no additional non-selenoprotein tran-
scripts down-regulated by Se deficiency. qRT-PCR con-
firmed microarray-detected Se-regulation for selected
genes up-regulated in Se deficiency, found expression
levels up to 8-fold higher in Se-deficient mouse liver,
and showed that these genes were restored to adequate
l e v e l si nt h em i c ef e daS em a r g i n a ld i e t( 0 . 0 5μgS e / g
diet) (Additional file 1, Figures S1A-S1F). In rats, qRT-
PCR confirmed that Abcc3 and Nqo1 were increased by
Se deficiency 4-fold and 2-fold relative to Se-adequate
levels, but also found that Abcc3 was increased by 5 μg
Se/g diet to levels not different from levels in Se-defi-
cient rat liver (Additional file 1, Figures S1G, S1H).
Transcriptional Effects of High Se
To determine whether there are transcripts regulated by
super-nutritional and toxic Se intakes, microarrays were
used to analyze expression in rats fed 8, 20 and 50-times
the Se requirement as compared to Se-adequate rats. Rat
study 1 determined the effect of Se status in rats fed up
to 0.8 μg Se/g, 8-times the requirement as compared
with Se-adequate rats (0.08 μgS e / gd i e t ) .S u r p r i s i n g l y ,
there were no significant gene expression changes with
this 10-fold increase in Se intake. When compared to
Se-adequate rats from study 2 (0.24 μgS e / gd i e t ) ,t h e r e
were 84 significant gene changes in rats fed 0.8 μgS e / g
diet, but these changes are likely due to differences
Figure 3 Effect of dietary Se on markers of liver damage.A L T
and AST activities in male weanling rats fed diets supplemented
with 0 to 5 μg Se/g diet for 28 d. Activities are expressed as mU/g
protein. Values are means ± SEM, n = 4/diet. The level of
significance by ANOVA is indicated; values with a common letter
are not significantly different (P ≥ 0.05).
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to Se status. RMA expression data plotted for several of
the transcripts altered in the 0.8 vs. 0.24 μgS e / gd i e t
comparison show that expression is changed at 0.8 and
to a lesser extent at 0.08, while remaining constant at the
other Se intakes (data not shown).
As no significant gene expression changes were observed
at 8-times the requirement, a second rat study was con-
ducted to assess transcriptional effects of Se intakes at
20 and 50-times the requirement (2 and 5 μgS e / gd i e t ) .
Gene expression in rats fed 2 and 5 μg Se/g diet was com-
pared with Se adequate rats (0.24 μgS e / gd i e t ) .O n l y
Figure 4 Effect of dietary Se on the transcriptome. RMA-generated expression values for all 31,099 probe sets on the Rat Genome 230 2.0
array were plotted for Se-deficient (A), 0.08 (B), 0.8 (C), 2 (D), and 5 μg Se/g diet (E) rat liver vs. 0.24 μg Se/g diet rat liver. Values are means, n =
3/diet. Solid black line is 1:1 expression. Dashed lines are 2-fold up- and down-regulated.
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Page 5 of 156 transcripts (5 genes and 1 EST) were significantly chan-
ged by 2 μg Se/g, with 5 others nearly significant (P < 0.2)
(Table 3). The genes up-regulated at 2.0 μgS e / gd i e tw e r e :
Rgs4, a regulator of g-protein signaling; Ccdc80, which
may be involved in extracellular matrix organization;
RGD1560666, a gene of unknown function that contains
putative signaling domains; and Oxct1, a member of
the 3-oxoacid CoA-transferase family. The lone down-
regulated gene at 20-times the requirement was Cirbp,
which contains RNA binding domains and is thought to
stabilize mRNAs and enhance translation.
In contrast to the few transcripts changed at 20-times
the Se requirement, there were 1193 transcripts signifi-
cantly altered at 50-times the requirement. As the rats
fed 5 μg Se/g diet had reduced growth and elevated
markers of liver damage, it was possible that many of
these transcripts could be responding to general toxicity
and/or caloric restriction. Therefore, the 1193 Se toxi-
city transcripts that overlapped with Affymetrix’sR a t -
ToxFX 1.0 array (218 of 2073 probe sets) and that
overlapped with 10 day caloric restriction (CalRestr)
data from a recent study (338 of 5391 probe sets) [29]
were removed, along with redundant transcripts for
genes found in RatTox or CalRestr datasets (Figure 5).
After filtering, 715 Se-specific transcripts remained in
this Se-specific dataset. This 715-transcript dataset con-
tained 48 duplicate transcripts, yielding 667 unique tran-
scripts which correspond to 437 unique genes for
subsequent GOMiner analyses. Most of the unique tran-
scripts were up-regulated, with 542 up- vs. 125 down-
regulated. GOMiner analysis identified 33 biological
processes significantly enriched in the Se-specific data-
set, and these were nearly all related to cell movement/
morphogenesis, extracellular matrix (ECM), and devel-
opment/angiogenesis (Table 4).
Unsupervised hierarchical clustering of the Se-specific
transcript expression for all 18 rat microarrays showed
the unique transcriptional response in the rats fed 5 μg
Se/g diet vs. lower Se intakes (Figure 6). Inspection of the
resulting treeview diagram identified clusters of high Se-
r e g u l a t e de x p r e s s i o ni nw h i c h2μg Se/g diet appeared to
have a similar, albeit more variable effect. Three clusters
containing 117 transcripts (72 genes) were up-regulated
to some extent by 2 as well as 5 μg Se/g diet, and one dis-
tinct cluster containing 44 transcripts (25 genes) was
down-regulated to some extent by 2 as well as 5 μgS e / g
diet (Figure 6). Functional analysis revealed a set of genes
within the clusters that were up-regulated by 2 and 5 μg
Table 1 Transcripts up-regulated by Se deficiency
Genbank Accession Gene Symbol Gene Title Fold Change
1 adj P-value
2 Nrf2 Target
3
Mouse Liver
NM_173047 Cbr3 carbonyl reductase 3 7.46 1.7E-05 X
NM_001033336 Abcc4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 3.73 0.023 X
NM_013560 Hspb1 heat shock protein 1 1.91 0.04
-----------------------
NM_008182 Gsta2 glutathione S-transferase, alpha 2 1.93 0.057
NM_007620 Cbr1 carbonyl reductase 1 1.89 0.057 X
NM_008706 Nqo1 NADPH dehydrogenase, quinone 1 1.85 0.073 X
NM_010357 Gsta4 glutathione S-transferase, alpha 4 1.74 0.17 X
Mouse Kidney
-----------------------
NM_001077353 Gsta3 glutathione S-transferase, alpha 3 1.74 0.076 X
NM_001033336 Abcc4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 1.89 0.11 X
NM_008706 Nqo1 NADPH dehydrogenase, quinone 1 1.64 0.29 X
Rat Liver
4
NM_173323 Ugt2b7 UDP glucuronosyltransferase 2 family, polypeptide B7 2.14 0.01
NM_001009920 Gsta5 glutathione S-transferase Yc2 subunit 3.03 0.02
-----------------------
NM_080581 Abcc3 ATP-binding cassette, sub-family C (CFTR/MRP), member 3 4.29 0.07 X
NM_033443 Arsb arylsulfatase B 1.40 0.07
NM_017000 Nqo1 NADPH dehydrogenase, quinone 1 1.99 0.16 X
Transcripts that were significantly (above dashed line, P < 0.05) or nearly significantly (below dashed line, 0.05 < P < 0.2) up-regulated in Se-deficient rodent
tissues compared to Se-adequate (0.2 or 0.24 μg Se/g diet, for mouse and rat studies respectively).
1Fold changes determined by analysis of RMA expression data
with the Limma package in R software,
2P-values were adjusted for multiple testing,
3Genes known to be Nrf2 targets, determined as described in the text,
4
Genes up-regulated in Se-deficient liver from rats in study 2.
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Page 6 of 15Se/g that are involved in glucose transport, insulin signal-
ing, or glycoprotein biosynthesis (Sort1, Sorbs1, Grb10,
Star, Chsy1, St3gal2, Stxbp1, Soat1).
Identification of High Se Molecular Biomarkers
Molecular biomarkers regulated by 2 μgS e / gm a yb e
useful in predicting high Se intake that is not yet overtly
toxic. Genes regulated by 2 μg Se/g showed several
unique expression patterns, which were confirmed by
qRT-PCR for the genes in Table 3. Rgs4 and Ccdc80
expression as assessed by qRT-PCR were up-regulated
8-fold and 2-fold by 2 μg Se/g, respectively, but to a les-
ser extent of 4-fold and 1.5-fold, respectively, by 5 μg
Se/g (Additional file 2, Figure S2A and S2B). Expression
of Oxct1 and RGD1560666 increased in a dose-response
fashion with increasing Se intake above the requirement,
reaching 2-fold and 1.5-fold, respectively, by 2 μgS e / g ,
and 3-fold and 2-fold, respectively, by 5 μgS e / g( A d d i -
tional file 2, Figure S2C and S2D). qRT-PCR, however,
did not confirm that Cirbp decreases with high Se sup-
plementation (Additional file 2, Figure S2E). In addition,
several genes with marginal differential expression at
Table 2 Transcripts down regulated by Se deficiency
Genbank Accession Gene Symbol Gene Title Fold Change
1 adj P-value
2 Nrf2 Target
3
Mouse Liver
NM_009156 Sepw1 selenoprotein W, muscle 1 -3.73 1.7E-05
NM_001033166 Selh selenoprotein H -2.83 0.0009
NM_008160 Gpx1 glutathione peroxidase 1 -2.14 0.0001
NM_019979 Selk selenoprotein K -2.14 0.0012
NM_013711 Txnrd2 thioredoxin reductase 2 -1.64 0.0091
NM_015762 Txnrd1 thioredoxin reductase 1 -1.57 0.099 X
Mouse Kidney
NM_001033166 Selh selenoprotein H -2.64 0.0004
NM_009156 Sepw1 selenoprotein W, muscle 1 -2.64 0.0044
NM_008160 Gpx1 glutathione peroxidase 1 -2.46 0.0039
Rat Liver
4
NM_001114939 Selh selenoprotein H -6.06 < 0.001
NM_030826 Gpx1 glutathione peroxidase 1 -3.73 < 0.001
NM_001014253 Selt selenoprotein T -1.60 0.005
NM_001106609 Txnrd3 thioredoxin reductase 3 -1.60 0.03
NM_022584 Txnrd2 thioredoxin reductase 2 -1.57 0.06
NM_207589 Selk selenoprotein K -2.46 0.07
Transcripts that were significantly (above dashed line, P < 0.05) or nearly significantly (below dashed line, 0.05 < P < 0.2) down-regulated in Se-deficient rodent
tissues compared to Se-adequate (0.2 or 0.24 μg Se/g diet, for mouse and rat studies respectively).
1Fold changes determined by analysis of RMA expression data
with the Limma package in R software,
2P-values were adjusted for multiple testing,
3Genes known to be Nrf2 targets, determined as described in the text,
4Genes down-regulated in Se-deficient liver from rats in study 2.
Table 3 Transcripts regulated by 2 μg Se/g diet
Genbank Accession Gene Symbol Gene Title Fold Change
1 adj P-value
2 Nrf2 Target
3
NM_017214 Rgs4 regulator of G-protein signaling 4 3.03 0.005 X
NM_022543 Ccdc80 coiled-coil domain containing 80 2.14 0.02
XM_001069576 RGD1560666 Similar to KIAA1280 protein 1.80 0.02
NM_001127580 Oxct1 3-oxoacid CoA transferase 1 1.64 0.02
NM_031147 Cirbp cold inducible RNA binding protein -1.83 0.02
BE107169 EST UI-R-BS1-ayq-f-06-0-UI.s1 1.70 0.03
NM_001009965 Tsku Tsukushin 2.30 0.13 X
NM_001011901 Hsph1 heat shock 105 kDa/110 kDa protein 1 1.68 0.13
NM_012886 Timp3 TIMP metallopeptidase inhibitor 3 1.68 0.13
AA945268 EST EST200767 -3.25 0.19
NM_001164396 RGD1564865 similar to 20-alpha-hydroxysteroid dehydrogenase -2.14 0.13
Transcripts that were significantly (above the dashed line, P < 0.05) or nearly significantly (below the dashed line, 0.05 < P < 0.2) differentially expressed in liver
from rats fed 2 μg Se/g diet compared to 0.24 μg Se/g diet.
1Fold changes determined by analysis of RMA expression data with the Limma package in R
software,
2P-values were adjusted for multiple testing,
3Genes known to be Nrf2 targets, determined as described in the text.
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to be significantly up-regulated 5-fold (Timp3) or down-
regulated 3-fold (RGD1564865) when analyzed using
qRT-PCR (Additional file 2, Figure S2G and S2H).
Individual expression values for the 6 transcripts regu-
lated by 2 μg Se/g and the 6 transcripts regulated by Se
deficiency in rat study 2 were subjected to multiple regres-
sion analysis against the individual liver Se concentrations,
with stepwise elimination of transcripts with non-signifi-
cant correlation coefficients (P > 0.05), to yield an equation
with the significant correlation coefficients that predicts
liver Se concentration, as described previously [30]. This
analysis resulted in a panel of 11 transcripts (6 regulated by
2 μg Se/g and 5 regulated by Se deficiency), with an overall
correlation coefficient of 0.9988 (P < 10
-6) that accounted
for 99% of the variation in liver Se concentration over the
full range from 0 to 5 μg Se/g diet (Figure 7). In contrast,
panels based on conventional liver selenoenzyme activity
biomarkers (Gpx1 plus Gpx4 activity) or blood selenoen-
zyme biomarkers (RBC Gpx1 plus plasma Gpx3 activity)
only predicted 57% or 80%, respectively, of the variability
in liver Se concentration.
Discussion
In all 3 studies presented here, Se deficiency did not sig-
nificantly affect growth, as observed in previous studies
[4,5]. In rat study 2, however, a high Se intake of 5 μg
Se/g diet significantly decreased growth as compared to
intakes ≤ 2 μgS e / gd i e t .G r o w t hd e f e c t sa n do t h e r
symptoms of Se toxicity resulting from intakes of 3 to
5 μg Se/g have been reported in previous studies
[1,31-33]. Although growth was not affected by Se defi-
ciency, liver Se, liver and RBC Gpx1 activity, and plasma
Gpx3 activity were all dramatically decreased in
Se-deficient mice and rats as compared to Se-adequate
animals. Gpx1 mRNA was also significantly down-regu-
lated in Se-deficient tissues, 2.1 to 3.7 fold, and mRNA
levels for several other selenoproteins were significantly
down-regulated by Se deficiency, as we previously
reported [8,26]. Thus, the Se-deficient animals were Se-
deficient at the biochemical and molecular level, but
otherwise indistinguishable from Se-adequate animals.
Liver Gpx1 activity was not further increased by super-
nutritional Se, and was slightly decreased by 5 μgS e / g
as compared to the Se-adequate diet (0.24 μgS e / g ) ,
most likely due to liver damage.
Microarray analysis of >30,000 transcripts in the liver
of rats fed Se deficient to 5 μg Se/g diet found that an
intake of 5 μg Se/g is required to alter the expression of
a large set of transcripts. This is the first report of a
large and distinct transcriptional response profile
induced by Se toxicity. In contrast, Se intakes less than
5 μg Se/g diet significantly changed < 10 transcripts as
compared to a Se-adequate intake within an experiment.
The distinct transcriptional effect of 5 μg Se/g correlates
with growth and ALT activity, the other markers of
toxicity measured in this study. The vastly expanded
number of gene expression changes observed in this
study thus is a newly-identified marker of Se toxicity.
Importantly, as many as half of the 1193 transcripts
altered by the 5 μg Se/g diet treatment may be Se-speci-
fic, as 715 transcripts still remained after removing
transcripts responding to general toxicity and caloric
restriction.
Previous microarray studies have investigated the tran-
scriptional effects of Se supplementation up to 1.0 μg
Se/g diet in rodents, of up to 200 μg Se/day in human
subjects, and of up to 22 μMS ei nc u l t u r e dc e l l s .
A search of the Se-regulated genes in 9 previous Se
microarray studies [11-18,34] found only a few genes
that were identified in more than 1 study. The only
genes regulated by >3 studies, however, were selenopro-
teins, suggesting that most of the genes identified were
not responding specifically to high Se. Many of these
studies are complicated by the fact that high Se treat-
ments were only compared to Se-deficient treatments,
so that many of the transcriptional changes are likely to
be the result of Se deficiency instead of Se supplementa-
tion. One study that did compare a high Se treatment to
a Se-adequate treatment (1.0 μgS e / gv s .0 . 2μgS e / g )
[13], found no significantly altered genes. Based on the
present study, it is very likely that the lack of Se-specific
regulation in these previous studies is due to insufficient
Se to cause large, significant transcriptional responses.
Figure 5 Identification of Se-specific probe sets regulated by 5
μg Se/g diet. The 1193 probe sets that were changed significantly
by 5 μg Se/g diet in rat study 2 as compared to 0.24 μg Se/g diet
were filtered to remove 260 non-specific transcripts overlapping
with probe sets changed significantly by caloric restriction (CalRestr),
to remove 140 transcripts included in the RatTox FX 1.0 array, and
to remove 78 transcripts found in both datasets. The resulting 715
high Se-transcript dataset contains 48 duplicate transcripts, yielding
667 unique transcripts which correspond to 437 unique genes.
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necessary to determine whether the transcripts identified
in the present study are truly Se-specific.
The levels of high Se in the present studies (8, 20 and
50-times the Se requirement) are relevant to high Se
intakes in humans. A study of Chinese subjects living in a
high Se area of China found no adverse effects of Se at
intakes of 800 μg/day (16X requirement) [35]. A small
supplementation trial in men with prostate cancer gave
subjects 1600 or 3200 μg Se/d as selenized yeast (32X
and 64X requirement) for about 12 months and found no
observable adverse effects in the group supplemented
with 1600 μg Se/d [36]. The subjects supplemented with
3200 μg Se/d, however, reported symptoms of Se toxicity,
and a few men reached plasma Se levels exceeding 1000
ng/ml, which was reported to be the threshold for the
o n s e to fS et o x i c i t yi nt h eC h i n e s es t u d y[ 3 5 ] .T h e s e
reports in humans agree with the observations from
the present study of no adverse effects of intakes up to
20-times the requirement and significant signs of Se
toxicity at intakes ≥50-times the requirement. Addition-
ally, the microarray data presented here indicates that
Table 4 Biological Processes enriched in Se-specific genes
GO Identifier Term Total Genes
1 Changed Genes
2 Enrich ment FDR
c
Cell movement/morphogenesis
GO:0006929 substrate-bound_cell_migration 11 4 9.37 0.032
GO:0007155 cell_adhesion 586 47 2.07 0.000
GO:0022610 biological_adhesion 586 47 2.07 0.000
GO:0008360 regulation_of_cell_shape 49 11 5.78 0.000
GO:0022604 regulation_of_cell_morphogenesis 126 18 3.68 0.000
GO:0000902 cell_morphogenesis 386 29 1.94 0.021
GO:0032989 cellular_component_morphogenesis 423 34 2.07 0.000
GO:0051128 regulation_of_cellular_component_organization 429 32 1.92 0.014
Extra cellular matrix
GO:0030199 collagen_fibril_organization 23 6 6.72 0.006
GO:0030198 extracellular_matrix_organization 88 14 4.10 0.000
GO:0030036 actin_cytoskeleton_organization 248 25 2.60 0.000
GO:0043062 extracellular_structure_organization 156 15 2.48 0.045
GO:0030029 actin_filament-based_process 263 25 2.45 0.000
GO:0007010 cytoskeleton_organization 417 33 2.04 0.001
Development/Angiogenesis
GO:0010926 anatomical_structure_formation 980 59 1.55 0.018
GO:0048856 anatomical_structure_development 2224 132 1.53 0.000
GO:0009653 anatomical_structure_morphogenesis 1158 78 1.74 0.000
GO:0022603 regulation_of_anatomical_structure_morphogenesis 260 27 2.68 0.000
GO:0048646 anatomical_structure_formation_involved_in_morphogenesis 346 30 2.23 0.000
GO:0001570 Vasculogenesis 40 8 5.15 0.004
GO:0001525 Angiogenesis 182 19 2.69 0.002
GO:0001568 blood_vessel_development 278 27 2.50 0.000
GO:0048514 blood_vessel_morphogenesis 237 23 2.50 0.000
GO:0001944 vasculature_development 282 27 2.47 0.000
GO:0009887 organ_morphogenesis 735 47 1.65 0.021
GO:0048731 system_development 2107 119 1.46 0.000
GO:0048869 cellular_developmental_process 1545 87 1.45 0.003
GO:0048513 organ_development 1633 91 1.44 0.004
GO:0007275 multicellular_organismal_development 2439 130 1.37 0.000
GO:0032502 developmental_process 2955 148 1.29 0.003
Other
GO:0034329 cell_junction_assembly 41 7 4.40 0.043
GO:0007165 signal_transduction 2543 127 1.29 0.020
GO:0032501 multicellular_organismal_process 3222 154 1.23 0.039
Gene ontology (GO) identifiers significantly enriched in the 667 Se-specific genes.
1Number of genes involved in this process in the set of all genes on the Rat
Genome 230 2.0 Array,
2Number of genes involved in this process in the set of genes specific to Se toxicity,
3False Discovery Rate - ratio of the number of times
the Se toxicity data gave P < 0.05 compared to a random set of data.
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ment are not sufficient to cause a large transcriptional
response. This is an important point because levels used
in cancer prevention trials are typically 200 μg/day, or
4-times the requirement, which will bring total Se intake
to 5 to 8-times the requirement depending on dietary Se
intake from foods. This data thus suggest that cancer
prevention associated with super-nutritional Se supple-
mentation may not be mediated by transcriptional
changes.
Se deficiency highly regulates the expression of some,
but not all selenoprotein mRNAs [5,8,26,37]. Most nota-
ble of the regulated selenoprotein genes is Gpx1, with
its expression dropping to < 10% of Se-adequate levels
in the rat model. Our recent studies have shown that in
addition to Gpx1, Sepw1 and Selh are also highly regu-
lated by Se deficiency and several other selenoprotein
mRNAs are moderately regulated [8,26]. Interestingly,
there were no additional non-selenoprotein genes found
to be down-regulated by Se deficiency, reinforcing the
Se-specificity of selenoprotein regulation. Importantly,
both microarray and qRT-PCR expression of the genes
up-regulated in Se deficiency show that like selenopro-
tein mRNAs, these genes are restored to adequate levels
i nt h em i c ef e daS em a r g i n a ld i e t( 0 . 0 5μgS e / gd i e t )
(Additional file 1, Figure S1).
A small set of genes were found to be significantly and
consistently up-regulated by Se deficiency. Comparison
of these genes with a dataset of 21 well-characterized
Nrf2-targeted genes containing Nrf2-binding sites [38]
plus a dataset of 1055 Nrf2-targeted genes identified
recently by ChiP analysis [39] revealed that the majority
Figure 6 5 μg Se/g diet elicits a unique transcriptional effect.
Unsupervised hierarchical clustering with RMA generated expression
values for the 667 unique Se-specific transcripts (Figure 5). Columns
represent liver expression from individual rats fed 0, 0.08, 0.24, 0.8, 2
and 5 μg Se/g diet. Rows represent probe sets. RMA gene expression
is shown using the indicated pseudocolor scale from -8X (green) to
+8X (red) relative to values for rats fed 0.24 μg Se/g. Clusters that are
up-regulated by 2 and 5 μg Se/g diet are highlighted in red and the
cluster down-regulated by 2 and 5 μg Se/g diet is highlighted in
green.
Figure 7 Prediction of liver Se by biomarker panels.L i v e rS e
concentration activity as determined by actual measurement or
calculated using biomarker panels based on liver Gpx1 plus liver
Gpx4 activities, based on RBC Gpx1 plus plasma Gpx3 activities, or
based on the 11-transcript molecular biomarker panel identified by
multiple regression analysis, as described in the text. Values are
means ± SEM.
Raines and Sunde BMC Genomics 2011, 12:26
http://www.biomedcentral.com/1471-2164/12/26
Page 10 of 15of the genes up-regulated by Se deficiency were Nrf2
targets (Table 1). NADPH dehydrogenase quinone 1
(Nqo1), a classic target of Nrf2 [40,41], did not reach
significance in this study, but was up-regulated 1.5 to 2
fold by Se-deficient treatments. Similarly, ABC transpor-
ters (also known as multidrug resistance proteins) and
glutathione S-transferases, are known targets of Nrf2
regulation [42,43], and were consistently up-regulated
by Se deficiency. Two of the up-regulated ABC trans-
porters, Abcc4 and Abcc3, are reported to be involved
in detoxification of a variety of drugs including acetami-
n o p h e n[ 4 4 ] .I nc o m p a r i s o n ,t h eo n l yg e n ed o w n - r e g u -
lated by Se-deficiency and overlapping with these Nrf2
datasets was thioredoxin reductase-1 in mouse liver
(Table 2). Two additional Nrf2 target genes, Rgs4 and
Tsku, were also found to be up-regulated by 2 μgS e / g
diet (Table 3). Overlap analysis of the 1193 transcripts
that were significantly altered by 5 μg Se/g diet and the
Nrf2-regulated gene datasetsi d e n t i f i e d9 9N r f 2t a r g e t s
that were differentially-regulated in Se toxicity (Addi-
tional file 3, Table S1), including 49 genes retained in
the Se-specific dataset. The prevalence of Nrf2-regulated
genes in genes significantly altered by Se toxicity as well
as up-regulated by Se deficiency indicates that Se excess
as well as Se deficiency increases oxidative stress.
Functional analysis of the genes in the Se-specific
dataset indicates their involvement in processes such as
cell movement/morphogenesis and development/angio-
genesis (Table 4). ECM-related genes were particularly
affected by Se toxicity. For example, collagen fibril orga-
nization was enriched by a factor of 6.72 (6 of 23 total
genes present in the Se-specific set, FDR = 0.006). The
genes in this category included four collagen genes
(Col12a1, Col5a2, Col1a2, Col11a1), one serine protei-
nase inhibitor (Serpinh1) and one annexin (Anxa2).
Further searching of the Se-specific dataset found a total
of seven collagen genes. In addition, many other ECM-
related genes were present in the 5 μg Se/g dataset. Col-
lagen genes were also reported to be regulated by Se-
methylselenocysteine in a prostate cancer cell line
(LNCaP), but only one of these (Col4a5) was regulated
in the same direction in the present study [17]. Addi-
tional evidence for an association between Se and col-
lagen metabolism comes from a study which found that
Se supplementation of rats with 0.3 μgS e / gd i e tf o r1 0
weeks increased collagen content of the skin, but
decreased it in other tissues including liver [45]. The
regulation of ECM components may also be relevant to
the anti-carcinogenic effect of Se as the ECM plays an
important role in cell migration and tumor progression.
In addition, collagen-regulation by Se may underlie
some physiologic effects of Se toxicity, as the symptoms
of Se toxicity include changes or malformations in
tissues comprised primarily of collagen, nails and hair in
humans and hooves in grazing animals [9,46].
Genes related to glucose metabolism were enriched
in the clusters that were up-regulated to some extent by
2a sw e l la s5μgS e / gd i e t .T h e r ei ss o m ee v i d e n c et h a t
high Se status is related to diabetes and it is known that
a selenosugar is one of the major excretory metabolites
for Se [24,25,47]. Se-regulation of glucose-related genes
may be another piece of the puzzle linking Se and glu-
cose metabolism.
We also conducted GOMiner analysis of the genes that
were removed from the original 1193-transcript toxic Se
dataset due to overlap with genes altered by general toxi-
city and/or calorie restriction. This analysis identified
90 significantly enriched (False Discovery Rate = FDR <
0.05) biological processes that were not specifically asso-
ciated with Se toxicity; these processes appeared to be
more varied than those found in the Se-specific dataset
(Additional file 4, Table S2).
Very few transcripts were significantly regulated by the
sub-toxic intake of 2 μg Se/g diet, but there were several
clusters of transcripts altered significantly by 5 μgS e / g
which were also variably affected by 2 μg Se/g diet. Two
of the conventional biomarkers, growth and ALT activ-
ity, suggest 5 but not 2 μg Se/g diet is toxic. AST activ-
ity, however, suggests that high Se intake at 2 μg Se/g as
well as in Se deficiency is also just beginning to cause
some liver damage. Previous studies have reported
adverse effects, such as reduced body weight and liver
damage, from Se intakes as low as 3 μgS e / g[ 3 1 ] .
Further studies are necessary to determine whether the
transcripts within the clusters similarly regulated by 2
and 5 μg Se/g diet would gain significance and correlate
with other markers of Se toxicity if studied at intakes
between 2 and 5 μg Se/g diet. As 2 μg Se/g diet borders
on a toxic Se intake, the 6 transcripts that were signifi-
cantly regulated by this treatment may prove to be use-
ful biomarkers of high Se intake before adverse effects
are observed.
To illustrate the potential utility of a small set of high Se
regulated transcripts as biomarkers of Se status, these
transcripts and those regulated by Se deficiency were used
successfully to predict liver Se concentration. Liver Se con-
centration was chosen as a marker of Se status for this
example because it represents a pool of Se that continues
to increase above the Se requirement, similar to hypotheti-
cal pools of Se associated with the anticarcinogenic activity
of Se. The resulting 11-gene biomarker panel accounted
for 99% of the variability in liver Se concentration across
the range from Se-deficient to toxic Se, illustrating the
potential of molecular biomarkers to predict Se status.
Comparison of the molecular biomarker panel curve in
Figure 7 with the conventional biomarker curves shown in
Raines and Sunde BMC Genomics 2011, 12:26
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markers are ineffective for assessment of high Se status.
The high Se regulated transcripts identified in this
study were associated with high Se intake in rats, but
these studies did not show that these changes are speci-
fic for super-nutritional or toxic Se status. The use of
transcript datasets associated with general toxicity or
calorie restriction reduced the dataset to 667 unique
transcripts which were more likely to be Se-specific,
but, as shown by the variety of biological processes
enriched in this dataset (Table 4), it is clear that most
of these transcripts are likely to be altered by a variety
of conditions, not just high Se. The molecular biomarker
panel, however, illustrates that it may be possible
to identify panels of these transcripts that collectively
can be specific for a condition such as high Se status.
Additional studies will be needed to further refine
the sets of Se-specific transcripts that can be used as
biomarkers and to uncover genes and processes asso-
ciated with Se homeostasis and the effects of high Se
supplementation.
Conclusion
This study showed that a Se intake which affected con-
ventional markers of toxicity in rats (5 μgS e / gd i e t )a l s o
altered the expression of 1193 transcripts when com-
pared to Se-adequate rats. High, but non-toxic Se intakes
(0.8 and 2 μg Se/g diet), however, produced very few
expression changes, providing the first evidence that a
vastly expanded number of transcriptional changes is a
biomarker of Se toxicity. Over half of the transcripts
regulated by Se toxicity may be Se-specific, as 715 tran-
scripts still remained after removing those responding to
general toxicity and caloric restriction. Genes that
respond specifically to Se toxicity are enriched in pro-
cesses related to the extracellular matrix, including a
number of collagen genes. In addition to down-regulating
selenoprotein genes, Se deficiency consistently up-regu-
lated several genes known to be targets of Nrf2 regula-
tion. The small set of transcripts significantly regulated
by 2 μg Se/g diet combined with those regulated by Se
deficiency was used to identify a biomarker panel that
over the range from Se-deficient to 50-times the require-
ment could account for 99% of the variability in liver Se
concentration. Further studies at Se intakes between
2a n d5μg Se/g diet will be needed to better define the
association between transcriptional changes and Se toxi-
city. In addition, microarray studies on toxic Se intakes
with other forms of Se such as selenomethionine, high Se
yeast and selenate may help to identify regulated tran-
scripts that are specific for different forms of Se and ide-
ally even to identify biomarkers specific for high Se status
regardless of Se form.
Methods
Reagents
Molecular biology reagents were purchased from Pro-
mega (Madison, WI), Invitrogen (Carlsbad, CA) or
S i g m a( S t .L o u i s ,M O ) .A l lo t h e rc h e m i c a l sw e r eo f
molecular biology or reagent grade.
Animals and Diets
Mouse Study
Male mouse pups from Se-adequate dams in our wild-
type colony (predominately C57 black background)
were weaned 18 days after birth and housed individu-
ally in hanging-wire cages, as described previously in
detail [26]. The basal Se-deficient diet was a torula-
yeast diet containing 0.005 μg Se/g by analysis, supple-
mented with 100 mg/kg all-rac-a-tocopherol acetate
and 0.4% L-methionine to prevent liver necrosis and
ensure adequate growth, as described previously [4].
Mice were fed the basal diet supplemented with 0,
0.05, or 0.2 μgS e / ga sN a 2SeO3 for 35 days (n = 3/
group) to provide Se-deficient, Se-marginal or Se-
adequate diets.
Rat Studies 1 and 2
Male, 21-day old weanling rats were obtained form
Holtzman (Madison, WI) and were housed individually
in hanging-wire cages. Study 1 rats were fed the basal
Se-deficient diet supplemented with graded levels of Se:
0, 0.016, 0.04, 0.06, 0.08, 0.12, 0.16, 0.24, 0.4 or 0.8 μg
Se/g diet as Na2SeO3 for 28 days (n = 6/group), as
described previously in detail [8]. Study 2 rats were fed
the basal diet supplemented with 0, 0.08, 0.24, 0.8, 2 or
5 μgS e / gd i e t( n=4 / g r o u p )f o r2 8d a y s .A l la n i m a l s
had free access to food and water and body weight was
measured bi-weekly. The care and treatment protocols
were approved by the University of Wisconsin Institu-
tional Animal Care and Use Committee.
Enzyme Activity Analysis
Tissue supernatants were prepared by homogenizing in
9 volumes of sucrose buffer [20 mM Tris/HCl, pH 7.4,
0.25 M sucrose, 1 mM EDTA and 0.1% peroxide-free
Triton X-100]. Homogenates were centrifuged at 10,000
g for 15 min at 4°C, model J2-21M, JA-21 rotor (Beck-
man Instruments, Palo Alto, CA). Gpx1 activity in liver,
kidney and red blood cells and Gpx3 activity in plasma
were measured by the coupled assay procedure using
120 μMH 2O2 [48]. Gpx4 activity was measured by the
coupled assay procedure using 78 μM phosphatidylcho-
line hydroperoxide, its specific substrate [5]. For both
assays, 1 unit is the amount of enzyme that will oxidize
one μmole of GSH per min under these conditions.
Alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) activity were measured in study 2 rat
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Page 12 of 15plasma using kits #318 and #319, respectively, following
the manufacturer’s protocol (Genzyme Diagnostics,
Charlottetown PE, Canada). The protein concentrations
of samples were determined by the method of Lowry
et al. [49]. Neutron activation analysis was kindly con-
ducted by the University of Missouri Research Reactor
to determine liver and diet Se concentrations [50]. NIST
SRM 1577 Bovine Liver was used as a certified quality
control sample for the liver analyses.
RNA isolation and microarray processing
Total RNA from mouse liver and kidney (n = 3/diet
group) was isolated with TRIzol Reagent (Invitrogen,
Carlsbad, CA) following the manufacturer’sp r o t o c o l .
Subsequently, mRNA was purified using an oligo-
dT-linked Oligotex resin (Qiagen, Valencia, CA). The
resulting mRNA (1 μg) was used to synthesize double
stranded cDNA [51], which was then purified and used
for in vitro transcription of biotin-labeled cRNA with
the Enzo BioArray HighYield RNATranscript Labeling
Kit. The cRNA was purified using an RNeasy kit
(Qiagen) and fragmented at 94°C for 35 min in a buffer
containing 200 mM Tris-Acetate, pH 8.0, 500 mM
potassium acetate, 150 mM magnesium acetate. Integ-
rity and size of total RNA, cRNA and fragmented cRNA
for each sample was determined by formaldehyde-agar-
ose gel electrophoresis. RNA or DNA obtained at each
step was quantitated using a ND-1000 UV-Vis Spectro-
photometer (NanoDrop Technologies, Wilmington, DE).
The mouse study used GeneChip Mouse Genome 430
2.0 arrays (Affymetrix, Santa Clara, CA), which contain
over 45,000 probe sets that target transcripts that repre-
sent over 34,000 mouse genes. Fragmented cRNAs and
GeneChip arrays were submitted to the Gene Expression
Center at UW-Madison for hybridization, washing and
scanning following standard manufacturer’s protocols.
Total RNA from rat liver was isolated as described
above and was then submitted to the Gene Expression
Center at UW-Madison for processing to cRNA, hybri-
dization, washing and scanning. The rat studies used
GeneChip Rat Genome 230 2.0 arrays (Affymetrix),
which contain over 31,000 probe sets that target tran-
scripts representing over 28,700 rat genes.
Microarray analysis
Robust Multichip Averaging (RMA) was used to correct
for background, normalize and generate expression data
[52]. The .CEL files for each microarray study were ana-
lyzed with the affy package within the Bioconductor
open-source project using ‘R’ statistical software [53].
Arrays were processed separately for each study and for
each tissue within the mouse study. The Limma (Linear
Models for Microarray Data) package was then used to
identify differentially expressed transcripts from the
RMA normalized data [54]. This package uses linear
models and Bayesian statistics to test the variance in
expression of each probe set on the array and P-values
are then adjusted for multiple testing. For each analysis
a contrast matrix was designed to identify differentially
expressed probe sets in each Se treatment group as
compared to the Se-adequate group (0.2 μg Se/g diet for
mice and 0.24 μg Se/g diet for rats). The arrays from rat
study 1 were also analyzed separately using RMA and
Limma to compare expression in 0.8 vs. 0.08 μgS e / g
diet rats. A probe set was considered differentially
expressed if the adjusted P-value was < 0.05. The micro-
array data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus [55] and
are accessible through GEO Series accession number
GSE23895
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE23895.
qRT-PCR analysis
Selected genes found to be differentially expressed by
microarray were validated with qRT-PCR as previously
described [26]. Relative expression was calculated using
the method of Pfaffl [56], normalized to the mean of con-
trol genes Actb and Gapdh and set relative to the mean
of Se-adequate animals. qRT-PCR and RMA expression
data are presented as mean “ SEM (n = 3/diet group).
Transcript Filtering, Clustering and Functional Analysis
Transcripts that were significantly regulated by Se toxi-
city (5 μg Se/g diet) were filtered to obtain a set of
Se-specific response transcripts. Transcripts in the Se
toxicity set were compared to transcripts on the Rat-
ToxFX 1.0 array (Affymetrix) and to probe sets altered
by caloric restriction in a recent study by Pohjanvirta
et al. [29]. Caloric restriction microarray data was down-
loaded from the Gene Expression Omnibus at NCBI
(GEO accession number = GSE9121) and independently
analyzed from the treatment restricting feed intake in
rats for 10 days vs. control rats. The probe sets found to
overlap between the Se toxicity set and these datasets
were then removed to enrich the data with Se-specific
transcripts. Additionally, redundant probe sets repre-
senting genes found to overlap between datasets were
removed from the Se toxicity set. Hierarchical clustering
was performed on the remaining transcripts using
RMA-calculated expression and visualization of the
resulting tree was done with Treeview software [57].
The GOMiner tool was used to identify biological pro-
cesses that were significantly enriched in the particular
datasets vs. all genes on the Rat 230 2.0 Genome
array [58]. A biological process was considered signifi-
cantly enriched if the false discovery rate (FDR) was less
than 0.05.
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Microarray expression values for potential biomarker
genes were regressed against corresponding liver Se con-
centrations using the Excel 2007 Data Analysis add-in,
as described previously [30]. Biomarkers with non-sig-
nificant coefficients were removed in a step-wise fashion
until all remaining biomarkers in the panel had signifi-
cant coefficients (P < 0.05).
Statistics
Animal growth, Se concentrations, enzyme activities and
relative expression data are presented as mean ± SEM.
For the mouse study and rat study 1, n = 3/group. For rat
s t u d y2 ,n=3o r4 / g r o u p .A l ld a t aw e r ea n a l y z e db y
ANOVA using a fixed model testing the main effect of
diet. Significant differences between means were assessed
by Duncan’s multiple range analysis (P < 0.05) [59].
Additional material
Additional file 1: Supplemental Figure S1. qRT-PCR and microarray
expression for selected genes up-regulated by Se-deficiency.
Additional file 2: Supplemental Figure S2. qRT-PCR and microarray
expression for genes regulated by 2 μg Se/g diet.
Additional file 3: Supplemental Table S1. List of known Nrf2-regulated
transcripts with altered expression in rats fed 5 μg Se/g diet.
Additional file 4: Supplemental Table S2. Full list of biological
processes enriched in genes removed from the original toxic Se data set
due to overlap with genes altered by general toxicity and/or calorie
restriction.
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